Condition
Vitreous Floaters
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07140692Not ApplicableCompletedPrimary
EFFECTIVENESS AND SAFETY ASSESSMENT OF THE VISTA VITRECTOMY PROBE
NCT06964867Not ApplicableRecruitingPrimary
Effectiveness of Multimedia Health Education to Reduce Anxiety in Patients With Vitreous Floaters
NCT06174935Phase 2UnknownPrimary
Low Dose Atropine for Symptomatic Vitreous Floaters
NCT01970267Not ApplicableCompleted
Clear Vision Study
Showing all 4 trials